食品伙伴网导读：FDA于2010年2月对西班牙的两家低酸罐头生产公司进行了检查，两家公司分别于5月27日和6月16日收到FDA对他们的运营提出的警告。主要是关于对生产过程信息的提供、温度的记录、温度差的控制等方面的要求。FDA警告：若不加整改，他们将被列为有“进口预警”的外国食品制造商，并在各口岸对其货物扣留。据悉，西班牙是美国最大的贸易伙伴之一，由于金融危机，2009年期间西班牙对美国的出口下降了29.1%。食品伙伴网对该报道进行了翻译整理，希望为我国的出口美国的低酸罐头生产厂家提供有用的参考信息。
原文导读：
FDA Warns Two Spanish Canned Food Facilities
by Dan Flynn | Jul 17, 2010
Two low-acid canned food facilities in Spain, inspected in February by the U.S. Food and Drug Administration (FDA), have recently received warning letters about their operations.
Industrias Alimentarias De Navarra, S.A.U., based in Villafranco Navarra northeast of Madrid, received a warning letter from FDA on May 27 about its canned black olives. Then in a June 16 warning letter to Cruz Perez Hermanos, S.A., located in Moana Pontevedra near Spain's west coast, FDA expressed concerns about Octopus in Oil.
FDA told both companies their imports to the United States could be impacted if they do not take prompt corrective action. FDA has the power to list foreign food manufacturers in its "Import Alert," and detain their products at the border.
FDA told De Navarra, which produces black olives, that it must determine and record temperatures during processing. It also asked the company to improve its methods for temperature process deviations.
Hermanos, S.A., which makes Octopus in Oil, was also told its product is "adulterated" because of violations of low-acid canned food regulations. FDA called out the company for:
-not providing process information.
-failing to use a mercury-in-glass (MIG) thermometer.
-failing to determine and record temperatures.
-no written record to visual observations.
Spain is one of the USA's top trading partners. The worldwide economic crunch led to a 29.1 percent decline in Spain's exports to the U.S during 2009 when the total reached $7.9 billion. The food sector that includes the Olives and Octopus being shipped by these two companies approached $300 million.
Spain imported goods worth $8.8 billion from the United States during 2009 for a trade surplus of about $900 million.
FDA gives foreign companies 30 days to respond to warning letters, and asks that responses be provided in English.
